Role of magnetic resonance imaging in the prediction of histological grade in soft tissue sarcomas

Author:

Marques Tomás Mansur Duarte de Miranda1ORCID,Cerqueira Wagner Santana2,Neto João Lisboa de Flores2,Kupper Bruna Elisa Catin1,Takahashi Renata Mayumi1,Bezerra Tiago Santoro1,Stevanato Filho Paulo Roberto1ORCID,Nakagawa Wilson Toshihiko1,Lopes Ademar1,Aguiar Samuel1

Affiliation:

1. Sarcoma Reference Center AC Camargo Cancer Center Sao Paulo Brazil

2. Department of Radiology, Sarcoma Reference Center AC Camargo Cancer Center Sao Paulo Brazil

Abstract

AbstractBackgroundSoft tissue sarcomas are rare malignant tumors with significant heterogeneity. The importance of classifying histological grades is fundamental to defining the treatment approach.ObjectiveTo evaluate magnetic resonance imaging (MRI) in predicting the histological grade of soft tissue sarcomas.MethodsA retrospective observational study included patients over 18 years undergoing MRI and primary tumor surgery at AC Camargo Cancer Center from January 2015 to June 2022. Two radiologists evaluated MRI criteria (size, margin definition, heterogeneity of the T2 signal, high‐intensity peritumoral signal on T2, and postperitumoral contrast), and a grading prediction score was calculated. χ2 and logistic regression analyses were conducted.ResultsSixty‐eight patients were included (38 men; median: 48 years). Moreover, 52 high‐grade and 16 low‐grade tumors were observed. The MRI criteria associated with histological grade were peritumoral high‐intensity T2‐weighted signals (p < 0.001) and peritumoral postcontrast enhancement (p = 0.006). Logistic regression confirmed their significance (odds ratio [OR]: 11.8 and 8.8, respectively). Each score point increment doubled the chance of high‐grade tumors (OR: 2.0; p = 0.014).ConclusionMRI effectively predicts histological grades of soft tissue sarcomas. Peritumoral high‐intensity T2‐weighted signals and peritumoral postcontrast enhancement are valuable indicators of high‐grade tumors. This highlights MRI's importance in treatment decision‐making for sarcoma patients.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3